As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...

Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.

Researchers explain how a drug that helps patients with neurological issues walk may also provide a surprising boost for the ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced ...

With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...

"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...

Aging brings many changes that can be unpleasant, from losing mobility to needing help with tasks that used to be easy. For those with Alzheimer's disease and other forms of ...

A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to ...